U.S. Markets
Eli Lilly’s (LLY) US prescriptions for Zepbound were 1,390 for the week ended April 10, according to IQVIA data
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
